BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $223,000 | -75.2% | 2,750 | -74.4% | 0.57% | +210.9% |
| Q4 2019 | $899,000 | -64.2% | 10,750 | -62.6% | 0.18% | +12.3% |
| Q3 2019 | $2,512,000 | -7.8% | 28,720 | -13.7% | 0.16% | 0.0% |
| Q2 2019 | $2,725,000 | +12.2% | 33,270 | +11.4% | 0.16% | +10.9% |
| Q1 2019 | $2,429,000 | +120.6% | 29,870 | +78.5% | 0.15% | +96.0% |
| Q4 2018 | $1,101,000 | -53.4% | 16,730 | -45.4% | 0.08% | -42.7% |
| Q3 2018 | $2,361,000 | +0.1% | 30,630 | -4.1% | 0.13% | -12.1% |
| Q2 2018 | $2,358,000 | +24.1% | 31,930 | +9.3% | 0.15% | +26.3% |
| Q1 2018 | $1,900,000 | +70.1% | 29,210 | +69.0% | 0.12% | +66.2% |
| Q4 2017 | $1,117,000 | -49.4% | 17,280 | -50.9% | 0.07% | -50.3% |
| Q3 2017 | $2,207,000 | +54.3% | 35,170 | +48.9% | 0.14% | +50.5% |
| Q2 2017 | $1,430,000 | +8.5% | 23,620 | -7.1% | 0.10% | +10.5% |
| Q1 2017 | $1,318,000 | -42.7% | 25,420 | -51.0% | 0.09% | -42.7% |
| Q4 2016 | $2,300,000 | +61.2% | 51,870 | +73.1% | 0.15% | +72.4% |
| Q3 2016 | $1,427,000 | -18.9% | 29,970 | -23.0% | 0.09% | -10.3% |
| Q2 2016 | $1,760,000 | +31.9% | 38,920 | +19.9% | 0.10% | +12.8% |
| Q1 2016 | $1,334,000 | +5.7% | 32,470 | -1.8% | 0.09% | +6.2% |
| Q4 2015 | $1,262,000 | +12.0% | 33,070 | -3.6% | 0.08% | +9.5% |
| Q3 2015 | $1,127,000 | -52.1% | 34,300 | +1.9% | 0.07% | -48.3% |
| Q2 2015 | $2,353,000 | -12.7% | 33,650 | -14.5% | 0.14% | -2.1% |
| Q1 2015 | $2,695,000 | -8.6% | 39,350 | -2.2% | 0.15% | -8.2% |
| Q4 2014 | $2,950,000 | -4.3% | 40,250 | -6.3% | 0.16% | -4.2% |
| Q3 2014 | $3,083,000 | -50.4% | 42,950 | -50.0% | 0.17% | -11.7% |
| Q2 2014 | $6,211,000 | -2.2% | 85,900 | -0.5% | 0.19% | -6.0% |
| Q1 2014 | $6,350,000 | -54.7% | 86,300 | -57.2% | 0.20% | -48.6% |
| Q4 2013 | $14,032,000 | +2.0% | 201,750 | -3.7% | 0.39% | -3.2% |
| Q3 2013 | $13,762,000 | -11.6% | 209,500 | -6.8% | 0.40% | -10.7% |
| Q2 2013 | $15,572,000 | – | 224,800 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |